Articles From: Interactive Intelligence Reports Second-Quarter 2013 Financial Results to Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results


2013/8/5
Interactive Intelligence Group Inc. (Nasdaq: ININ) , a global provider of software and services designed to improve the customer experience, has announced financial results for the three and six months ended June 30, 2013.
Sign-up for Interactive Intelligence Reports Second-Quarter 2013 Financial Results investment picks
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, has announced financial results for the three and nine months ended Sept.
Sign-up for Interactive Intelligence Reports Third-Quarter 2013 Financial Results investment picks
2013/10/15
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, has scored highest overall in technology assessment measures in Ovum’s Decision Matrix: Selecting a Multichannel Cloud Contact Center Vendor report.
Sign-up for Interactive Intelligence Shortlisted as Market Leader in Ovum’s Multichannel Cloud Contact Center Vendor Report; Scores Highest Overall in Technology Assessment Measures investment picks
2014/1/13
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, will issue its fourth-quarter and full year financial results for the period ended Dec.
Sign-up for Interactive Intelligence to Announce Fourth-Quarter and Full Year 2013 Financial Results investment picks
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, will issue its third-quarter financial results for the period ended Sept.
Sign-up for Interactive Intelligence to Announce Third-Quarter 2013 Financial Results investment picks
2013/8/1
Interactive Intelligence Group Inc. (Nasdaq: ININ) , a global provider of software and services designed to improve the customer experience, is hosting a complimentary Web event titled, “ Delivering Social Customer Service – More than Just Having a Presence on Facebook, Twitter, and LinkedIn ,” to be held Tuesday, Aug.
Sign-up for Interactive Intelligence to Host “Delivering Social Customer Service” Industry Web Event investment picks
2014/1/16
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, is hosting a no-cost Web event titled, “Key 2014 Contact Center Trends and Priorities: How You Can Be Ready,” to be held Tuesday, Jan.
Sign-up for Interactive Intelligence to Host “Key 2014 Contact Center Trends and Priorities” Industry Web Event investment picks
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, is hosting a CX Day networking event Tuesday, Oct.
Sign-up for Interactive Intelligence to Host CXPA Customer Experience Networking Event investment picks
2013/10/4
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, is hosting a regional Canadian customer conference, to be held Oct.
Sign-up for Interactive Intelligence to Host Regional Canadian Customer Conference in Montreal investment picks
Interactive Intelligence Group Inc. (Nasdaq:ININ), a global provider of software and services designed to improve the customer experience, is launching Interaction Content Manager ™ (ICM), a media-independent software application that captures, indexes, stores, searches, accesses and manages business-critical content.
Sign-up for Interactive Intelligence to Launch Content Management Solution investment picks
2013/12/2
Interactive Intelligence Group Inc. (Nasdaq: ININ) CFO Stephen R.
Sign-up for Interactive Intelligence to Present at J.P. Morgan SMid Cap Conference investment picks
Interactive Intelligence Group Inc. (Nasdaq: ININ) CFO Stephen R.
Sign-up for Interactive Intelligence to Present at RBC Capital Markets’ Technology, Internet, Media and Telecommunications Conference investment picks
2014/2/24
Interactive Intelligence Group Inc. (Nasdaq: ININ) CFO Stephen R.
Sign-up for Interactive Intelligence to Present at Upcoming Investor Conferences investment picks
2014/2/28
Interactive Intelligence Group Inc. (Nasdaq:ININ), a global provider of software and services designed to improve the customer experience, has published the agenda for its annual INTERACTIONS 2014 customer and partner conference, to be held June 2-5 at the JW Marriott in Indianapolis, Indiana, U.S.A. The global conference will feature keynotes from Aron Ralston, whose autobiography, “Between a Rock and a Hard Place,” was the subject of the film “127 Hours”; and Jay Baer, social media expert and New York Times best-selling author of the book, “YOUTILITY: Why Smart Marketing is About Help Not Hype.” At the conference, Interactive Intelligence founder and CEO Dr.
Sign-up for Interactive Intelligence Unveils Agenda for Global Customer and Partner Conference investment picks
2014/3/18
Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, has unveiled its Global Alliance Program .
Sign-up for Interactive Intelligence Unveils Global Alliance Program investment picks
2013/10/30
Technology Marketing Corp’s. Cloud Computing Magazine has honored Interactive Intelligence Group Inc. (Nasdaq: ININ) with a 2013 Cloud Computing Excellence Award.
Sign-up for Interactive Intelligence Wins Cloud Computing Excellence Award from TMC investment picks
Interactive Intelligence Group Inc. (Nasdaq: ININ), a Gold level member of Oracle PartnerNetwork (OPN), has achieved Oracle Validated Integration of the latest version of its IP communications software suite, Customer Interaction Center ™ (CIC) 4.0, with Oracle (RightNow) Cloud Service.
Sign-up for Interactive Intelligence’s Customer Interaction Center™ Achieves Oracle Validated Integration with Oracle Cloud Service investment picks
2013/9/24
Interactive Intelligence Group Inc. (Nasdaq: ININ), a Gold level member of Oracle PartnerNetwork (OPN), has achieved Oracle Validated Integration of the latest version of its IP communications software suite, Customer Interaction Center ™ (CIC) 4.0 with Oracle Sales Cloud.
Sign-up for Interactive Intelligence’s Customer Interaction Center™ Achieves Oracle Validated Integration with Oracle Sales Cloud investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1071211&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for InterActive Leisure Systems Inc. Announces Results of Investigation Into $250,000 Note to Pacific Park Investments LLC investment picks
2014/2/3
Interactive Retailer HSNi Opens L.A. Office with UEG to Develop Exciting New Partnerships that will Elevate its Unparalleled Portfolio of Lifestyle Brands NEW YORK and ST.
Sign-up for Interactive Retailer HSNi Announces United Entertainment Group to Become Marketing Partnership Agency of Record investment picks
2014/3/16
-OCA Meets Primary Endpoint With High Statistical Significance of p < 0.0001 -Company to Conduct Conference Call and Webcast March 17, 2014 at 8:30 a.m. ET NEW YORK, March 16, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced that its international Phase 3 POISE trial of obeticholic acid (OCA) for the treatment of primary biliary cirrhosis (PBC) demonstrated that OCA, at both a 10 mg dose and a 5 mg dose titrated to 10 mg, met the trial's primary endpoint of achieving a reduction in serum alkaline phosphatase (ALP) to < 1.67x ULN with a ≥ 15% reduction from baseline and a normal bilirubin level after 12 months of therapy.
Sign-up for Intercept Announces Positive Pivotal Phase 3 POISE Trial Results investment picks
2014/4/11
- Study Presented at EASL 2014 Named Best Oral Abstract in Basic Science at Annual Meeting - NEW YORK, April 11, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced results from a preclinical study demonstrating the potential protective effects of the Company's lead product candidate obeticholic acid (OCA) in an experimental model of liver disease.
Sign-up for Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis investment picks
2013/10/8
NEW YORK , Oct.
Sign-up for Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders investment picks
2014/2/18
NEW YORK, Feb.
Sign-up for Intercept Expands Its Board of Directors With Appointments of Sanj K. Patel and Glenn Sblendorio investment picks
2014/3/14
NEW YORK, March 14, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on key development programs.
Sign-up for Intercept Pharmaceuticals Announces 2013 Financial Results investment picks
2014/4/3
NEW YORK, April 3, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced the pricing of its previously announced underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $320.00 per share.
Sign-up for Intercept Pharmaceuticals Announces Pricing of Public Offering investment picks
2014/4/1
NEW YORK, April 1, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced that it has commenced an underwritten public offering of 1,000,000 shares of its common stock.
Sign-up for Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock investment picks
NEW YORK , Aug.
Sign-up for Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results investment picks
2013/11/14
NEW YORK , Nov.
Sign-up for Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Interactive Intelligence Reports Second-Quarter 2013 Financial Results to Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity